Content area
Full Text
Life and health
Centene Corp. will divest a pair of pharmacy businesses for total proceeds of about $2.8 billion, Dow Jones Newswires reported. The health insurer plans to sell pharmacy solutions organization Magellan Rx to Prime Therapeutics LLC, and agreed to sell specialty and rare pharmacy Pantherx Rare to a consortium of Vistria Group, General Atlantic and Nautic Partners.
Genworth Financial Inc. experienced elevated mortality in its long-term care insurance line during the first quarter, but executives largely expect mortality in the troubled business line will return to a "more normalized level" over the course of 2022. The higher mortality over the period was consistent with nationwide COVID-19 trends and reflected both the surge of the omicron variant and seasonal mortality patterns, CFO Daniel Sheehan said.
Property and casualty
A judge...